Examination of the optimal lipid-lowering therapy in patients with type 2 diabetes complicated with dyslipidemia.
Phase of Trial: Phase II
Latest Information Update: 06 Mar 2012
At a glance
- Drugs Ezetimibe; Pravastatin
- Indications Dyslipidaemias; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 06 Mar 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 21 Oct 2011 New trial record